Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001213900-25-034047·Sofgen Pharma S.A.
Schedule 13D ownership disclosure
PROCAPS GROUP
Ordinary Shares, nominal value of $0.01 per share · CUSIP: L7756P102
Event date: 2025-04-09
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Saint Thomas Commercial S.A.Reported CIK 0002064752
Shares: 2,077,549,443.00 · Class: 84.38%
- Santana S.A.Reported CIK 0002064751
Shares: 2,077,549,443.00 · Class: 84.38%
- Leonidas Vial Echeverria
Shares: 2,077,549,443.00 · Class: 84.38%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-034047
- Form type
- SCHEDULE 13D
- Filer
- Sofgen Pharma S.A.
- CIK
- CIK 1863362
- Filed
- Apr 22, 2025
- Reporting period
- Apr 09, 2025
- Description
- Schedule 13D beneficial ownership